Ascept
  • Home
  • About ASCEPT
    • What is Pharmacology/Toxicology?
    • Clinical Pharmacology
    • History
    • Honour Roll/Life Members Page
  • Join ASCEPT
  • Members
    • Renew
    • Awards and Prizes
    • Travel Grants
    • Member Spotlight
    • Benefits
      • Mentoring Program
    • Special Interest Groups
    • Mentoring Program
  • Annual Scientific Meeting 2012
  • Annual Scientific Meeting 2011
    • Welcome
    • Program
    • Speakers
    • Workshops
    • Special Interest Groups
    • Awards and Prizes
    • Travel Grants
    • Social Program
    • Sponsors & Exhibitors
  • New Zealand Conference
  • Events
  • News & Media
    • E-News
    • Media
  • Past Annual Scientific Meetings
    • 2010
      • Proceedings
      • Speakers
      • Accommodation
      • Program
      • Venue
      • Sponsors & Exhibitors
  • Special Interest Groups
    • Clinical Pharmacology
    • Drug Discovery
    • Education
      • Carrick Project
    • Pharmacogenomics
    • Gastrointestinal Urogenital Pharmacology
    • Toxicology
    • Cardiovascular
    • Drug Disposition and Response
  • ASCEPT Sponsors
  • ASCEPT FORUMS
  • SEAWP-RFP
  • Educational Resource
    • Core Curricula
    • Teaching Software
  • Careers/Jobs
  • Council and Committees
  • Contact Us
Ascept
Site Map

Ascept

Contact Ascept

Drug Disposition and Response

  • Home
  •  > 
  • Special Interest Groups
  •  > 
  • Drug Disposition and Response
Welcome to the Drug Disposition and Response Special Interest Group. Go to the Drug Disposition and Response Forum  (re-opening soon).

At the AGM the Drug Disposition SIG resolved to change its name to "Drug Disposition and Response" to better reflect the interests of its members.  It was also decided that the SIG would have two Co-chairs (rather than a Chair and Co-chair/Secretary).

The committee are:

Co-chair: Andrew Rowland (Flinders University)

Co-chair: David Foster (University of South Australia)

Education forum representative: Kathy Knights (Flinders University)
Student representative: TBA
Ascept